|
GOLPH3L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.605200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.048600E-01 |
| Normal-vs-Stage2 |
9.626800E-01 |
| Normal-vs-Stage3 |
4.606400E-02 |
| Normal-vs-Stage4 |
1.797850E-02 |
| Stage1-vs-Stage2 |
8.065000E-01 |
| Stage1-vs-Stage3 |
6.122300E-02 |
| Stage1-vs-Stage4 |
2.571900E-02 |
| Stage2-vs-Stage3 |
1.674970E-01 |
| Stage2-vs-Stage4 |
1.320440E-01 |
| Stage3-vs-Stage4 |
7.574600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.706600E-01 |
| Normal-vs-AfricanAmerican |
8.16310000000264E-05 |
| Normal-vs-Asian |
4.239200E-01 |
| Caucasian-vs-AfricanAmerican |
2.780800E-04 |
| Caucasian-vs-Asian |
7.569800E-01 |
| AfricanAmerican-vs-Asian |
2.810200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.909560E-01 |
| Normal-vs-Female |
2.276400E-01 |
| Male-vs-Female |
9.669400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.402500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.238000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.135630E-01 |
| Normal-vs-Age(81-100Yrs) |
6.794600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.530640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.008400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.254400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.142200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.270400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.490400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.675000E-01 |
| Normal-vs-Grade 2 |
9.303400E-01 |
| Normal-vs-Grade 3 |
1.836200E-01 |
| Normal-vs-Grade 4 |
5.757400E-04 |
| Grade 1-vs-Grade 2 |
6.687200E-01 |
| Grade 1-vs-Grade 3 |
3.559200E-01 |
| Grade 1-vs-Grade 4 |
2.899900E-02 |
| Grade 2-vs-Grade 3 |
1.918980E-01 |
| Grade 2-vs-Grade 4 |
4.764400E-04 |
| Grade 3-vs-Grade 4 |
1.895800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.028100E-02 |
| Normal-vs-ccB subtype |
1.157860E-02 |
| ccA subtype-vs-ccB subtype |
2.28660000001213E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.966800E-01 |
| Normal-vs-N1 |
6.963000E-01 |
| N0-vs-N1 |
9.423000E-01 |
|
|
